Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Sortilin is associated with breast cancer aggressiveness and contributes to tumor cell adhesion and invasion.

Roselli S, Pundavela J, Demont Y, Faulkner S, Keene S, Attia J, Jiang CC, Zhang XD, Walker MM, Hondermarck H.

Oncotarget. 2015 Mar 18. [Epub ahead of print]

2.

Docosahexaenoic acid inhibits the invasion of MDA‑MB‑231 breast cancer cells through upregulation of cytokeratin‑1.

Blanckaert V, Kerviel V, Lépinay A, Joubert-Durigneux V, Hondermarck H, Chénais B.

Int J Oncol. 2015 Mar 27. doi: 10.3892/ijo.2015.2936. [Epub ahead of print]

PMID:
25825023
3.

Nerve-Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression.

Jobling P, Pundavela J, Oliveira SM, Roselli S, Walker MM, Hondermarck H.

Cancer Res. 2015 Mar 20. [Epub ahead of print] Review.

PMID:
25795709
4.

Proteogenomics: emergence and promise.

Faulkner S, Dun MD, Hondermarck H.

Cell Mol Life Sci. 2015 Mar;72(5):953-7. doi: 10.1007/s00018-015-1837-y. Epub 2015 Jan 22.

PMID:
25609363
5.

NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.

Bradshaw RA, Pundavela J, Biarc J, Chalkley RJ, Burlingame AL, Hondermarck H.

Adv Biol Regul. 2014 Nov 20. pii: S2212-4926(14)00062-1. doi: 10.1016/j.jbior.2014.11.003. [Epub ahead of print]

PMID:
25491371
6.

ProNGF correlates with Gleason score and is a potential driver of nerve infiltration in prostate cancer.

Pundavela J, Demont Y, Jobling P, Lincz LF, Roselli S, Thorne RF, Bond D, Bradshaw RA, Walker MM, Hondermarck H.

Am J Pathol. 2014 Dec;184(12):3156-62. doi: 10.1016/j.ajpath.2014.08.009. Epub 2014 Oct 5.

PMID:
25285721
7.

Antiproliferative and apoptotic effects of the oxidative dimerization product of methyl caffeate on human breast cancer cells.

Bailly F, Toillon RA, Tomavo O, Jouy N, Hondermarck H, Cotelle P.

Bioorg Med Chem Lett. 2013 Jan 15;23(2):574-8. doi: 10.1016/j.bmcl.2012.11.009. Epub 2012 Nov 22.

PMID:
23228470
8.

Neurotrophins and their receptors in breast cancer.

Hondermarck H.

Cytokine Growth Factor Rev. 2012 Dec;23(6):357-65. doi: 10.1016/j.cytogfr.2012.06.004. Epub 2012 Jun 30. Review.

PMID:
22749855
9.

Proteome changes induced by overexpression of the p75 neurotrophin receptor (p75NTR) in breast cancer cells.

Wilmet JP, Tastet C, Desruelles E, Ziental-Gelus N, Blanckaert V, Hondermarck H, Le Bourhis X.

Int J Dev Biol. 2011;55(7-9):801-9. doi: 10.1387/ijdb.113345jw.

10.

Pro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein.

Demont Y, Corbet C, Page A, Ataman-Önal Y, Choquet-Kastylevsky G, Fliniaux I, Le Bourhis X, Toillon RA, Bradshaw RA, Hondermarck H.

J Biol Chem. 2012 Jan 13;287(3):1923-31. doi: 10.1074/jbc.M110.211714. Epub 2011 Nov 29.

11.

Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.

Vanhecke E, Adriaenssens E, Verbeke S, Meignan S, Germain E, Berteaux N, Nurcombe V, Le Bourhis X, Hondermarck H.

Clin Cancer Res. 2011 Apr 1;17(7):1741-52. doi: 10.1158/1078-0432.CCR-10-1890. Epub 2011 Feb 24.

12.

Ku86 is important for TrkA overexpression-induced breast cancer cell invasion.

Lagadec C, Romon R, Tastet C, Meignan S, Com E, Page A, Bidaux G, Hondermarck H, Le Bourhis X.

Proteomics Clin Appl. 2010 Jul;4(6-7):580-90. doi: 10.1002/prca.200900148. Epub 2010 Mar 26.

PMID:
21137076
13.

Overexpression of p75(NTR) increases survival of breast cancer cells through p21(waf1).

Verbeke S, Meignan S, Lagadec C, Germain E, Hondermarck H, Adriaenssens E, Le Bourhis X.

Cell Signal. 2010 Dec;22(12):1864-73. doi: 10.1016/j.cellsig.2010.07.014. Epub 2010 Jul 24.

PMID:
20667470
14.

Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways.

Romon R, Adriaenssens E, Lagadec C, Germain E, Hondermarck H, Le Bourhis X.

Mol Cancer. 2010 Jun 22;9:157. doi: 10.1186/1476-4598-9-157.

15.

Role of endothelial progenitor cells in breast cancer angiogenesis: from fundamental research to clinical ramifications.

Le Bourhis X, Romon R, Hondermarck H.

Breast Cancer Res Treat. 2010 Feb;120(1):17-24. doi: 10.1007/s10549-009-0686-5. Epub 2009 Dec 24. Review.

PMID:
20033768
16.

Cancer proteomics--an evolving battlefield. Conference on Cancer Proteomics 2009: Mechanistic Insights, Technological Advances & Molecular Medicine.

Collins BC, Lau TY, O'Connor DP, Hondermarck H.

EMBO Rep. 2009 Nov;10(11):1202-5. doi: 10.1038/embor.2009.222. Epub 2009 Oct 2. No abstract available.

17.

TrkA overexpression enhances growth and metastasis of breast cancer cells.

Lagadec C, Meignan S, Adriaenssens E, Foveau B, Vanhecke E, Romon R, Toillon RA, Oxombre B, Hondermarck H, Le Bourhis X.

Oncogene. 2009 May 7;28(18):1960-70. doi: 10.1038/onc.2009.61. Epub 2009 Mar 30.

PMID:
19330021
18.

Identification of new p53 acetylation sites in COS-1 cells.

Joubel A, Chalkley RJ, Medzihradszky KF, Hondermarck H, Burlingame AL.

Mol Cell Proteomics. 2009 Jun;8(6):1167-73. doi: 10.1074/mcp.M800487-MCP200. Epub 2009 Jan 19.

19.

The proteome of the human breast cancer cell line MDA-MB-231: Analysis by LTQ-Orbitrap mass spectrometry.

Strande V, Canelle L, Tastet C, Burlet-Schiltz O, Monsarrat B, Hondermarck H.

Proteomics Clin Appl. 2009 Jan;3(1):41-50. doi: 10.1002/prca.200800083. Epub 2008 Dec 9.

PMID:
21136935
20.

A novel H19 antisense RNA overexpressed in breast cancer contributes to paternal IGF2 expression.

Berteaux N, Aptel N, Cathala G, Genton C, Coll J, Daccache A, Spruyt N, Hondermarck H, Dugimont T, Curgy JJ, Forné T, Adriaenssens E.

Mol Cell Biol. 2008 Nov;28(22):6731-45. doi: 10.1128/MCB.02103-07. Epub 2008 Sep 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk